Q3 2024 Holdings
Filed 2024-11-14 | 196 holdings | $6.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $343.0M | 632,829 | 5.6% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $315.4M | 7,874,400 | 5.1% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $265.7M | 571,406 | 4.3% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $244.1M | 496,775 | 4.0% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $222.5M | 809,095 | 3.6% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $220.9M | 4,871,360 | 3.6% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $214.7M | 1,863,800 | 3.5% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $205.5M | 2,452,797 | 3.3% |
| Abbott Labs(ABT) | COM | 002824100 | $198.8M | 1,743,938 | 3.2% |
| Stryker Corporation(SYK) | COM | 863667101 | $190.2M | 526,607 | 3.1% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $181.9M | 2,485,627 | 2.9% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $166.0M | 3,735,915 | 2.7% |
| Incyte Corp(INCY) | COM | 45337C102 | $142.2M | 2,150,551 | 2.3% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $131.9M | 225,550 | 2.1% |
| Moderna Inc(MRNA) | COM | 60770K107 | $107.0M | 1,600,836 | 1.7% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $104.4M | 3,071,615 | 1.7% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $102.0M | 2,040,853 | 1.7% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $98.7M | 1,449,465 | 1.6% |
| Caredx Inc(CDNA) | COM | 14167L103 | $98.2M | 3,145,456 | 1.6% |
| Insulet Corp(PODD) | COM | 45784P101 | $98.1M | 421,479 | 1.6% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $90.8M | 1,008,633 | 1.5% |
| Becton Dickinson & Co(BDX) | COM | 075887109 | $81.4M | 337,633 | 1.3% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $78.5M | 1,850,891 | 1.3% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $75.5M | 2,670,050 | 1.2% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $74.8M | 1,134,076 | 1.2% |
| Dexcom Inc(DXCM) | COM | 252131107 | $68.2M | 1,017,038 | 1.1% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $58.8M | 2,386,600 | 1.0% |
| Penumbra Inc(PEN) | COM | 70975L107 | $53.0M | 272,683 | 0.9% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $52.2M | 7,377,184 | 0.8% |
| Option Care Health Inc(OPCH) | COM NEW | 68404L201 | $51.8M | 1,654,878 | 0.8% |
| GE Healthcare Technologies I(GEHC) | COMMON STOCK | 36266G107 | $49.9M | 531,967 | 0.8% |
| Procept Biorobotics Corp(PRCT) | COM | 74276L105 | $49.1M | 612,691 | 0.8% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $47.8M | 7,879,583 | 0.8% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $46.7M | 432,805 | 0.8% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $46.5M | 114,525 | 0.8% |
| Elevance Health Inc(ELV) | COM | 036752103 | $46.5M | 89,328 | 0.8% |
| Idexx Labs Inc(IDXX) | COM | 45168D104 | $46.1M | 91,279 | 0.7% |
| Cooper COS Inc(COO) | COM | 216648501 | $43.8M | 397,373 | 0.7% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $43.0M | 344,348 | 0.7% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $41.5M | 1,600,000 | 0.7% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $41.2M | 195,080 | 0.7% |
| The Cigna Group(CI) | COM | 125523100 | $41.0M | 118,407 | 0.7% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $39.2M | 44,246 | 0.6% |
| Resmed Inc(RMD) | COM | 761152107 | $39.1M | 160,128 | 0.6% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $38.4M | 525,434 | 0.6% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $38.1M | 1,428,929 | 0.6% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $37.5M | 1,205,464 | 0.6% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $37.2M | 1,518,121 | 0.6% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $37.1M | 8,517,839 | 0.6% |
| Align Technology Inc(ALGN) | COM | 016255101 | $36.6M | 143,996 | 0.6% |